Fenofibrate dramatically shortens treatment time for severe Covid-19 patients – new clinical trials show
A team at the Hebrew University of Jerusalem (HU) is reporting “astounding” results from a trial to check the efficacy of the lipid-lowering drug TriCor (fenofibrate) as a treatment for patients with severe Covid-19. In earlier research, the team at HU, lead by Professor Yaakov Nahmias, reported that the new coronavirus causes abnormal accumulation […]
